FRCS (ORL-HNS) · SECTION 1 SBA

Ménière disease escalation

A patient has disabling unilateral Ménière attacks despite dietary measures and maintenance treatment. Hearing remains serviceable. Which escalation principle is most appropriate?

CHOOSE ONE ANSWER

Best of five

  1. A. Proceed directly to labyrinthectomy
  2. B. Prescribe indefinite vestibular suppressants
  3. C. Offer bilateral gentamicin
  4. D. Use shared decision-making to select the least destructive effective option before ablative treatment
  5. E. Avoid discussing hearing risk because vertigo is the only outcome
ANSWER AND REASONING

D. Use shared decision-making to select the least destructive effective option before ablative treatment

Escalation should balance vertigo control against hearing and vestibular loss. Intratympanic steroid is non-ablative; gentamicin and surgery carry increasing destructive risk and should follow careful counselling and local specialist pathways.

Why every option is right or wrong

A. Proceed directly to labyrinthectomy: Labyrinthectomy sacrifices residual hearing and is not the first escalation with serviceable hearing.

B. Prescribe indefinite vestibular suppressants: Long-term suppressants do not modify the disorder and may impair compensation.

C. Offer bilateral gentamicin: Bilateral vestibulotoxic treatment risks severe oscillopsia and imbalance.

D. Use shared decision-making to select the least destructive effective option before ablative treatment: Escalation should balance vertigo control against hearing and vestibular loss. Intratympanic steroid is non-ablative; gentamicin and surgery carry increasing destructive risk and should follow careful counselling and local specialist pathways.

E. Avoid discussing hearing risk because vertigo is the only outcome: Hearing preservation is central to treatment choice.

What if the scenario changed?

If hearing were already non-serviceable with incapacitating unilateral disease, an ablative option could become proportionate after specialist assessment.

EDUCATIONAL USE

Independent Clinora educational preparation material; not official JCIE content, an accredited programme, clinical advice, or a substitute for current guidance, local policy and specialist judgement.

Back to the Section 1 bank